索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]杨晨曦,徐迎佳.B细胞在动脉粥样硬化中的作用[J].国际心血管病杂志,2016,06:358-361.
点击复制

B细胞在动脉粥样硬化中的作用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年06期
页码:
358-361
栏目:
综述
出版日期:
2016-11-20

文章信息/Info

Title:
-
作者:
杨晨曦; 徐迎佳
200030 上海交通大学附属胸科医院心内科
Author(s):
-
关键词:
动脉粥样硬化; B淋巴细胞; 体液免疫
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.06.011
文献标识码:
-
摘要:
动脉粥样硬化是发生在大中动脉血管壁的慢性炎症反应。不同的B细胞亚群,通过分泌不同的抗体或细胞因子,在动脉粥样硬化的发展过程中发挥着不同作用。该文介绍了关于B细胞在动脉粥样硬化中的作用。
Abstract:
-

参考文献/References

[1] Lichtman AH, Binder CJ, Tsimikas S, et al. Adaptive immunity in atherogenesis: new insights and therapeutic approaches[J]. J Clin Invest, 2013, 123(1): 27-36.
[2] Melchers F.Checkpoints that control B cell development[J]. J Clin Invest. 2015,125(6):2203-2210.
[3] Caligiuri G, Nicoletti A, Poirier B, et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice[J]. J Clin Invest, 2002, 109(6):745-753.
[4] Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice[J]. Arterioscler Thromb Vasc Biol, 2002, 22(11):1892-1898.
[5] Kyaw T, Tay C, Khan A, et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis[J]. J Immunol, 2010, 185(7):4410-4419.
[6] Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice[J]. J Exp Med, 2010, 207(8):1579-1587.
[7] Kyaw T, Tay C, Hosseini H, et al.Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation[J]. PLoS One, 2012, 7(1):e29371.
[8] Sage AP, Tsiantoulas D, Baker L, et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice-brief report[J].Arterioscler Thromb Vasc Biol, 2012, 32(7):1573-1576.
[9] Doran AC, Lipinski MJ, Oldham SN, et al.B-cell aortic homing and atheroprotection depend on Id3[J]. Circ Res, 2012, 110(1):e1-12.
[10] Ravandi A,Boekholdt SM, Mallat Z, et al. Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study[J]. J Lipid Res, 2011, 52(10):1829-1836.
[11] Hansson GK, Nilsson J. Vaccination against atherosclerosis? Induction of atheroprotective immunity[J]. Semin Immunopathol, 2009, 31(1):95-101.
[12] Hernández-Vargas P, Ortiz-Muñoz G, López-Franco O, et al. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice[J]. Circ Res, 2006,99(11):1188-1196.
[13] Kelly JA, Griffin ME, Fava RA, et al. Inhibition of arterial lesion progression in CD16-deficient mice:evidence for altered immunity and the role of IL-10[J]. Cardiovasc Res, 2010, 85(1):224-231.
[14] Mendez-Fernandez YV, Stevenson BG, Diehl CJ, et al. The inhibitory FcγRⅡb modulates the inflammatory responseand influences atherosclerosis in male apoE(-/-)mice[J]. Atherosclerosis, 2011, 214(1):73-80.
[15] Wang J, Cheng X, Xiang MX, et al. IgE stimulates human and mouse arterial cell apoptosis andcytokine expression and promotes atherogenesis in Apoe-/- mice[J]. J Clin Invest, 2011, 121(9):3564-3577.
[16] Smith DD, Tan X, Raveendran VV, et al.Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice[J]. Am J Physiol Heart Circ Physiol,2012,302(12):H2612-2621.
[17] Hilgendorf I, Theurl I, Gerhardt LM, et al. Innate response activator B cells aggravate atherosclerosis by stimulating TH1 adaptive immunity[J]. Circulation, 2014, 129(16):1677-1687.
[18] Teichmann LL, Schenten D, Medzhitov R, et al. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus[J]. Immunity, 2013, 38(3):528-540.
[19] Shaposhnik Z, Wang X, Weinstein M, et al. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions[J]. Arterioscler Thromb Vasc Biol, 2007, 27(3):621-627.
[20] Haghighat A, Weiss D, Whalin MK, et al. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice[J]. Circulation, 2007, 115(15):2049-2054.
[21] Kyaw T, Tipping P, Bobik A, et al. Protective role of natural IgM-producing B1a cells in atherosclerosis[J]. Trends Cardiovasc Med, 2012, 22(2):48-53.
[22] Kyaw T, Tay C, Krishnamurthi S, et al.B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions[J]. Circ Res,2011, 109(8):830-840.
[23] Rosenfeld SM, Perry HM, Gonen A, et al.B-1b cells secrete atheroprotective IgM and attenuate atherosclerosis[J]. Circ Res, 2015, 117(3):e28-39.
[24] Lewis MJ, Malik TH, Ehrenstein MR, et al. Immunoglobulin M isrequired for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice[J].Circulation, 2009, 120(5):417-426.
[25] Lampropoulou V, Hoehlig K, Roch T, et al. TLR-activated B cells suppress T cell-mediated autoimmunity[J]. J Immunol, 2008, 180(7):4763-4773.
[26] Chou MY, Hartvigsen K, Hansen LF,et al. Oxidation-specific epitopes are important targets of innate immunity[J]. J Intern Med, 2008, 263(5):479-488.
[27] Faria-Neto JR, Chyu KY, Li X, et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice[J]. Atherosclerosis, 2006, 189(1): 83-90.
[28] Boullier A, Gillotte KL, Hörkkö S,et al. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein[J]. J Biol Chem, 2000, 275(13): 9163-9169.
[29] Ogden CA, Kowalewski R, Peng Y, et al. IgM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo[J].Autoimmunity, 2005, 38(4):259-264.
[30] Sage AP, Nus M, Baker LL,et al. Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice[J]. Arterioscler Thromb Vasc Biol, 2015, 35(8):1770-1773.
[31] Fernández-Nebro A, Rúa-Figueroa Í, López-Longo FJ, et al. Cardiovascular events in systemic lupus erythematosus: A Nationwide Study in Spain From the RELESSER Registry[J]. Medicine(Baltimore), 2015, 94(29):e1183.
[32] Pego-Reigosa JM, Lu TY, Fontanillo MF, et al.Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study [J].Rheumatology(Oxford), 2010, 49(4):691-696.

备注/Memo

备注/Memo:
通信作者:徐迎佳,Email:lucy.yingjia@gmail.com
更新日期/Last Update: 2016-11-20